REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 117 filers reported holding REVOLUTION MEDICINES INC in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,119,324 | +4.3% | 40,438 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $1,073,183 | +48.9% | 40,119 | +20.6% | 0.00% | 0.0% |
| Q1 2023 | $720,672 | +6.0% | 33,272 | +16.6% | 0.00% | 0.0% |
| Q4 2022 | $679,894 | +22.4% | 28,543 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $555,572 | +21.8% | 28,173 | +20.3% | 0.00% | 0.0% |
| Q2 2022 | $456,000 | -23.6% | 23,413 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $597,000 | +1.4% | 23,413 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $589,000 | -8.3% | 23,413 | +0.4% | 0.00% | 0.0% |
| Q3 2021 | $642,000 | -13.2% | 23,326 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $740,000 | -12.7% | 23,326 | +26.3% | 0.00% | -50.0% |
| Q1 2021 | $848,000 | +27.5% | 18,473 | +10.0% | 0.00% | +100.0% |
| Q4 2020 | $665,000 | +49.4% | 16,797 | +31.4% | 0.00% | 0.0% |
| Q3 2020 | $445,000 | – | 12,779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 685,011 | $13,508,000 | 35.31% |
| TRV GP III, LLC | 3,604,130 | $71,073,000 | 31.03% |
| Nextech Invest Ltd. | 4,189,529 | $82,618,000 | 26.68% |
| Column Group LLC | 4,577,840 | $90,275,000 | 19.98% |
| Ponoi Management, LLC | 685,011 | $13,508,000 | 18.44% |
| TRV GP IV, LLC | 1,419,900 | $28,000,000 | 16.36% |
| Boxer Capital, LLC | 3,984,264 | $78,570,000 | 4.42% |
| Casdin Capital, LLC | 2,522,300 | $49,740,000 | 3.27% |
| Cormorant Asset Management, LP | 1,995,066 | $39,343,000 | 2.75% |
| BVF INC/IL | 3,255,588 | $64,200,000 | 2.65% |